Ensuring the global Covid-19 vaccine equity

Lockdowns and other COVID-19 containment measures enforced to kerb the pandemic have had a massive impact on the overall growth of the world. Income-generating activities have been reduced, but the impact is more consequential among the low- and middle-income countries. The disproportionate access to vaccines between wealthy and poor countries has resulted in 'vaccine apartheid.' An 'every-country-for-itself' approach or 'vaccine nationalism' coupled with 'vaccine hesitancy' has contributed to disproportionate access to and uptake of the COVID-19 vaccines. This paper argues that it is time for the decision-makers to adopt a Universal Vaccine Access Strategy (UVAS). The authors argue that sharing resources by establishing local production of vaccines wherever possible, timely donation of unused COVID-19 vaccines to developing countries and addressing vaccine hesitancy have become imperative to interrupt the emergence of new variants

Business · Context (archaeology · Coronavirus disease 2019 (COVID-19 · Developing country · Development economics · Disease · Economic growth · Economics · Equity (law · Geography · Infectious disease (medical specialty · Pandemic · Political science · Vaccination · COVID-19 epidemiological studies · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Virology

• The ‘Other’ face of health security

  Open Access•Max D López Toledano, Mervat Alhaffar et al.•PLOS Global Public Health•2026

  Incluir item

• Lessons learnt from Covid-19 to reduce mortality and morbidity in the Global South

  Open Access•Rebecca R Martin, Allan Maleche et al.•BMJ Global Health•2024

  Incluir item

• Reconceptualizing vaccine nationalism

  Open Access•Guangyi Pan, Mengying Yang et al.•Technological Forecasting and…•2025

  Incluir item

• Covid-19 vaccination and governance in the case of low, middle and high-income countries

  Open Access•Dan Lupu, Ramona Țigănașu•BMC Public Health•2023

  Incluir item

• Covid-19 vaccine hesitancy in a representative working-age population in France

  Open Access•Michaël Schwarzinger, Verity Watson et al.•The Lancet Public Health•2021

  Incluir item

• Beyond confidence

  Open Access•Cornelia Betsch, Peter Schmid et al.•PLoS ONE•2018

  Incluir item

• A future vaccination campaign against Covid-19 at risk of vaccine hesitancy and politicisation

  Open Access•Patrick Peretti-Watel, Valérie Seror et al.•The Lancet Infectious Diseases•2020

  Incluir item

• Strategies for addressing vaccine hesitancy – A systematic review

  Open Access•Caitlin Jarrett, Rose Wilson et al.•Vaccine•2015

  Incluir item

• Challenges in ensuring global access to Covid-19 vaccines

  Open Access•Olivier J Wouters, Kenneth C Shadlen et al.•The Lancet•2021

  Incluir item

• Combating the Covid-19 infodemic

  Open Access•Sambit Dash, Ateeb Ahmad Parray et al.•BMJ Global Health•2021

  Incluir item

• Stronger together

  Open Access•Shashika Bandara, Soumyadeep Bhaumik et al.•BMJ Global Health•2021

  Incluir item

• Socioeconomic impacts of Covid-19 in low-income countries

  Open Access•Ake Josephson, Tugba Kilic et al.•Nature Human Behaviour•2021

  Incluir item